NCT02147561View on ClinicalTrials.gov

A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic Migraine

PHASE4CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Migraine Disorders
Interventions
BIOLOGICAL

botulinum toxin Type A

Botulinum toxin Type A injected across specific head and neck muscles on Day 0.

Trial Locations (1)

Unknown

Seoul

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY